A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models
Authors
Keywords
Autoimmune, Coxsackievirus, Enterovirus, Neutralising antibodies, Non-obese diabetic mouse, Type 1 diabetes, Vaccine
Journal
DIABETOLOGIA
Volume 58, Issue 2, Pages 346-354
Publisher
Springer Nature
Online
2014-11-05
DOI
10.1007/s00125-014-3436-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Type I Interferon Transcriptional Signature Precedes Autoimmunity in Children Genetically at Risk for Type 1 Diabetes
- (2014) R. C. Ferreira et al. DIABETES
- Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility
- (2014) H. Kallionpaa et al. DIABETES
- Developing a vaccine for Type 1 diabetes through targeting enteroviral infections
- (2014) Heikki Hyöty et al. Expert Review of Vaccines
- Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination
- (2014) Markku Partinen et al. LANCET NEUROLOGY
- The autoimmune basis of narcolepsy
- (2013) Josh Mahlios et al. CURRENT OPINION IN NEUROBIOLOGY
- Virus Antibody Survey in Different European Populations Indicates Risk Association Between Coxsackievirus B1 and Type 1 Diabetes
- (2013) S. Oikarinen et al. DIABETES
- Coxsackievirus B1 Is Associated With Induction of -Cell Autoimmunity That Portends Type 1 Diabetes
- (2013) O. H. Laitinen et al. DIABETES
- Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice
- (2013) P. G. Larsson et al. DIABETOLOGIA
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Induction of an Antiviral State and Attenuated Coxsackievirus Replication in Type III Interferon-Treated Primary Human Pancreatic Islets
- (2013) K. Lind et al. JOURNAL OF VIROLOGY
- The case for virus-induced type 1 diabetes
- (2013) Isabella Spagnuolo et al. Current Opinion in Endocrinology Diabetes and Obesity
- Prevention or acceleration of type 1 diabetes by viruses
- (2012) Liana Ghazarian et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Type 1 Diabetes Is Associated With Enterovirus Infection in Gut Mucosa
- (2012) M. Oikarinen et al. DIABETES
- Type 1 diabetes associated and tissue transglutaminase autoantibodies in patients without type 1 diabetes and coeliac disease with confirmed viral infections
- (2012) Luis Sarmiento et al. JOURNAL OF MEDICAL VIROLOGY
- Enterovirus Infection and Progression From Islet Autoimmunity to Type 1 Diabetes: The Diabetes and Autoimmunity Study in the Young (DAISY)
- (2010) L. C. Stene et al. DIABETES
- Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host
- (2010) Didier Hober et al. Nature Reviews Endocrinology
- Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity
- (2010) Mikael Knip et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes
- (2009) S. J. Richardson et al. DIABETOLOGIA
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study
- (2009) Christopher C Patterson et al. LANCET
- Insulin as an autoantigen in NOD/human diabetes
- (2008) Li Zhang et al. CURRENT OPINION IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started